| Olorofim Aspergillus Infection Study (NCT05101187) | F2G Biotech GmbH | 2022-03-31 |
| Incidence of Invasive Aspergillosis and Its Relation to Galactomannan Clinical Outcomes (NCT07621263) | Hospital H+ Queretaro | 2022-03-01 |
| European Study of Cerebral Aspergillosis Treated With Isavuconazole (NCT04486885) | Imagine Institute | 2021-08-01 |
| Azole-echinocandin Combination Therapy for Invasive Aspergillosis (NCT04876716) | Erasmus Medical Center | 2021-05-11 |
| A Study to Understand How the Use of Paxlovid Affected the Healthcare Use in People With Pre-existing Conditions. (NCT04550936) | Pfizer | 2021-03-10 |
| Posaconazole (MK-5592) Intravenous and Oral in Children With Invasive Aspergillosis (IA) (MK-5592-104) (NCT04218851) | Merck Sharp & Dohme LLC | 2020-07-02 |
| Amphotericin B Cholesteryl Sulfate Complex for Injection(ABCD) in the Treatment of Invasive Candidiasis and Invasive Aspergillosis (NCT04225195) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2020-01-01 |
| A Study to Evaluate Isavuconazonium Sulfate for the Treatment of Invasive Aspergillosis (IA) or Invasive Mucormycosis (IM) in Pediatric Participants (NCT03816176) | Astellas Pharma Global Development, Inc. | 2019-08-22 |
| Posaconazole Pharmacokinetics in Patients Receiving Chemotherapy or Stem Cell Transplants (NCT03717623) | Melbourne Health | 2019-08-01 |
| Radiolabelled IV and Oral Metabolism Study of F901318 (NCT02912026) | F2G Ltd | 2019-05-01 |
| VL-2397 Compared to Standard First-Line Treatment for Invasive Aspergillosis (IA) in Adults (NCT03327727) | Vical | 2018-02-20 |
| Detection of Azole Resistance Inducing Mutations on DNA Extracted Directly From Serum or Plasma of Immunocompromised Patients With an Invasive Aspergillus Infection Azole Resistance PCR Optimalization-study (NCT06069505) | Bart Rijnders | 2017-07-01 |
| Drug/Drug Interactions With F901318 (NCT03095547) | F2G Ltd | 2017-05-01 |
| Pharmacokinetics of IV Formulation (NCT03076905) | F2G Ltd | 2017-05-01 |
| Clinical Implications of Azole-Resistant Aspergillosis in Hematological Malignancy (NCT03221075) | University Hospital of Cologne | 2017-03-01 |
| Multiple Ascending Oral Dose Study of F901318 in Healthy Subjects (NCT02737371) | F2G Ltd | 2016-05-01 |
| Study of Potential for Interaction of Fluconazole With F901318 (NCT02730442) | F2G Ltd | 2016-02-01 |
| Impact of Pre-existing Invasive Aspergillosis on Allogeneic Stem Cell Transplantation (NCT03014934) | European Society for Blood and Marrow Transplantation | 2016-01-01 |
| Evaluation of the Potential for Cytochrome P450 3A4 Inhibition by F901318 Using Oral Midazolam as a Probe (NCT02680808) | F2G Ltd | 2016-01-01 |
| Single Ascending Oral Dose Study of F901318 (NCT02394483) | F2G Ltd | 2015-10-01 |
| Concentrations of Voriconazole in Blood and BAL-fluid After Inhalation and Oral Administration (NCT02396225) | University of Aarhus | 2015-03-01 |
| F901318 Multiple Ascending Dose Study (NCT02342574) | F2G Ltd | 2015-02-01 |
| Influence of a Combined Pharmacogenetic Score on Through Plasma Voriconazole Concentrations in Haematological Patients (NCT03067350) | University Hospital, Grenoble | 2015-01-01 |
| F901318 Single Ascending Dose Study in Healthy Male Volunteers (NCT02142153) | F2G Ltd | 2014-08-01 |
| Post Marketing Study to Evaluate the Efficacy and Safety of Micafungin Treatment on Invasive Aspergillosis (NCT02646774) | Astellas Pharma China, Inc. | 2014-03-01 |
| An Evaluation of Sequential Computed Tomography of the Chest in Management of Invasive Pulmonal Aspergillosis in Neutropenic Patients With Haematological Malignancies (NCT02773342) | University Hospital of Cologne | 2013-06-01 |
| Exhaled Breath Analysis in the Early Detection of Aspergillosis (NCT02106117) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2012-12-01 |
| Natural History of Individuals With Immune System Problems That Lead to Fungal Infections (NCT01386437) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-11-05 |
| Diagnostic Study of Biomarkers in BAL of ICU Patients With Lung Infiltrates (NCT01695499) | Heidelberg University | 2012-08-01 |
| Diagnostic Study of Combined Biomnarker Testing in Bronchoalveolar Lavage Samples of Immunocompromised Patients (NCT01695512) | Heidelberg University | 2012-08-01 |
| Correlation Between Circulating Galactomannan and Beta-D-glucan and Clinical Outcome of Invasive Aspergillosis (NCT01176071) | University Hospital, Gasthuisberg | 2010-07-01 |
| Validation of an Index of Neutropenia (D-index) in Febrile Neutropenic Cancer Patients (NCT00982540) | Universidade Federal do Rio de Janeiro | 2010-02-01 |
| A Study To Evaluate The Safety Of Voriconazole As Treatment Of Invasive Aspergillosis (Fungal Infection) And Other Rare Molds In Children (NCT00836875) | Pfizer | 2009-05-01 |
| Invasives Aspergillosis in Acute Myeloid Leukemia (NCT02900430) | University Hospital, Brest | 2009-01-01 |
| Influence of Drug-drug Interactions on the Pharmacokinetics (PK) of Voriconazole (NCT01080651) | Seoul National University Hospital | 2008-12-01 |
| Diagnostic and Management Strategies for Invasive Aspergillosis (NCT00816088) | King's College Hospital NHS Trust | 2008-12-01 |
| Diagnosing Pulmonary Aspergillosis in Patients With Hematological Malignancies: A Multicentre Prospective Evaluation of an Aspergillus PCR Assay and a Galactomannan ELISA in Bronchoalveolar Lavage Samples (NCT01430663) | Heidelberg University | 2007-04-01 |
| Surveillance for Nosocomial Infections in Pediatric Cancer Patients (NCT00843804) | University Hospital, Bonn | 2007-03-01 |
| Galactomannan Antigen in Bronchoalveolar Lavage in the Diagnosis of Invasive Aspergillosis in Neutropenic Patients (NCT01128907) | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 2006-10-01 |
| Caspofungin Maximum Tolerated Dose in Patients With Invasive Aspergillosis (NCT00404092) | University of Cologne | 2006-10-01 |
| Micafungin Salvage Mono-therapy in Invasive Aspergillosis (NCT00376337) | Astellas Pharma Inc | 2006-06-01 |
| A Multicentre Randomised Controlled Trial Comparing Two Strategies for the Diagnosis of Invasive Aspergillosis in High-risk Haematology Patients (NCT00163722) | Bayside Health | 2005-09-01 |
| Study Safety/Efficacy of AmBisome Loading Dose Regimen Versus Standard AmBisome Regimen for Initial Treatment (NCT00158730) | Gilead Sciences | 2003-04-01 |
| Invasive Aspergillosis After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) (NCT00838643) | Ospedale Santa Croce-Carle Cuneo | 2002-05-01 |
| Diagnosing Invasive Aspergillosis by Polymerase Chain Reaction (PCR) Based Investigation of Bronchoalveolar Lavage Samples During Antifungal Therapy (NCT01448226) | Heidelberg University | 2000-01-01 |